Unlicensed applications of licensed psychotropic drugs in an intellectual disability clinical service: retrospective case-note study

Author:

Ghosh Soumya1,Arulrajan Arum E.2,Baldwin David3

Affiliation:

1. Hertfordshire Partnership NHS Foundation Trust, UK,

2. Hampshire Partnership NHS Foundation Trust, UK

3. University of Southampton School of Medicine, UK

Abstract

Prescribing of psychotropic drugs for unlicensed indications is common in inpatients with intellectual disability, but the frequency in the community is uncertain. This study examined the medical records of all patients undergoing review within a single service led by a consultant psychiatrist. The notes of 114 individuals with varying degrees of disability and independence were available. In 78 percent of individuals the cause of disability was uncertain; 72, 69 and 78 percent had mental health problems, physical ill-health and behavioural challenges respectively; and 66 percent received licensed drugs for unlicensed applications, principally for aggression, risperidone being the drug most prescribed. There were no significant differences between groups with mild, moderate or severe disability in the proportion receiving licensed and unlicensed prescriptions. Unlicensed prescribing was similarly common for patients living in different settings. Prescribing for unlicensed applications in patients with intellectual disability is common, regardless of degree of disability or place of residence.

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,Health Professions (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3